title: Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.
abstract: OBJECTIVE
  Characterization of current morbidity and mortality among heart failure (HF) outpatients in Galicia (N.W. Spain), together with their main determinants.
  
  
  METHODS
  Prospective multicentre study involving 149 primary care physicians.
  
  
  METHODS
  Primary care physicians selected randomly from among all (1959) primary care physicians in Galicia.
  
  
  METHODS
  Clinical and epidemiological information for 1195 outpatients with HF were collected in 2006, with a mean follow-up of 6.5+/-1.5 months.
  
  
  METHODS
  Survival rates were calculated by Cox's proportional hazard model.
  
  
  RESULTS
  Mean patient age was 76 years, 48% were male, 82% had a history of arterial hypertension, and 32% ischaemic cardiopathy. Echocardiography had been performed in 67%, showing preserved systolic function in 61%. Ninety-two (8%) died during follow-up [74 (80%) of them from cardiac causes], and 313 (29%) were re-admitted to hospital [230 (73%) of them for cardiac reasons]. Multivariate analysis identified the following independent predictors of cardiovascular death and/or readmission: ischaemic cardiopathy [hazard ratio (HR) 1.76, 95% confidence interval (CI) 1.29-4.40], stroke (HR 1.79, CI 1.18-2.73), oedema (HR 1.49, CI 1.10-2.03), anaemia (HR 1.66, CI 1.21-2.27), deteriorated systolic function (HR 1.62, CI 1.19-2.20), and previous cardiovascular admissions (HR 2.33, CI 1.67-3.24). Residence in the Barbanza district was identified as an independent predictor of survival free from cardiovascular admission (HR 0.56, CI 0.37-0.86).
  
  
  CONCLUSIONS
  Morbidity and mortality are currently high among Galician HF patients, and their best single predictor is previous hospitalization for cardiovascular reasons.
authors.affiliation: Sección de Coordinación Asistencial, SERGAS, Santiago de Compostela, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Otero-Raviña
authors.forename: Lilian
authors.initials: L
authors.lastname: Grigorian-Shamagian
authors.forename: Luis
authors.initials: L
authors.lastname: Fransi-Galiana
authors.forename: Carlos
authors.initials: C
authors.lastname: Názara-Otero
authors.forename: José M A
authors.initials: JM
authors.lastname: Fernández-Villaverde
authors.forename: Alberto
authors.initials: A
authors.lastname: del Alamo-Alonso
authors.forename: Enrique
authors.initials: E
authors.lastname: Nieto-Pol
authors.forename: Miguel
authors.initials: M
authors.lastname: de Santiago-Boullón
authors.forename: Isidro
authors.initials: I
authors.lastname: López-Rodríguez
authors.forename: José M A
authors.initials: JM
authors.lastname: Cardona-Vidal
authors.forename: Alfonso
authors.initials: A
authors.lastname: Varela-Román
authors.forename: José R
authors.initials: JR
authors.lastname: González-Juanatey
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000453:epidemiology* / Q000401:mortality*; D006801:Humans; D008297:Male; D009017:Morbidity; D010343:Patient Admission; D011446:Prospective Studies; D013030:Spain / Q000453:epidemiology; D015996:Survival Rate / Q000639:trends